All of Biotech and Money's content, in one place.
The landscape of innovation and investment in the healthcare sector has cha...
Read MoreIP portfolio management is often overlooked, but is extremely important if ...
Read MoreHealthcare is the hottest new sector for start-ups when it comes to new tec...
Read MoreOn Tuesday 6 February 2018, leading life sciences companies will share thei...
Read MoreOn Tuesday 6 February 2018, leading life sciences companies will share thei...
Read MoreOn Tuesday 6 February 2018, leading life sciences companies will share thei...
Read MoreIn February 2017, Gill Jennings & Every reported on the preliminary opinion...
Read MoreOn Tuesday 6 February 2018, leading life sciences companies will share thei...
Read More
In February 2017, Biotech and Money published its 1st Investor perception s...
Read MoreThe advanced therapy sector is a rapidly growing industry which offers subs...
Read MoreThe global therapeutic IPO market has failed to maintain the upward momentu...
Read MoreKey learnings: The Cybersecurity Law came into effect in China’s territorie...
Read MoreThis blog is a summary of Chapter 6 of the Advanced Therapies Investment Re...
Read MoreThis blog is a summary of Chapter 5 of the Advanced Therapies Investment Re...
Read MoreThis blog is a summary of Chapter 4 of the Advanced Therapies Investment Re...
Read MoreThis blog is a summary of Chapter 3 of the Advanced Therapies Investment Re...
Read More
Sinclair Dunlop, Managing Partner at Epidarex Capital Venture capital firm ...
Read MoreJulz Co focuses on healthcare investments across the US, Europe, and Asia-P...
Read MoreWe recently sat with Edward Van Wezel, Managing Director and Founder of Bio...
Read MoreOur latest investorview this week is with Christoph Ruedig, Partner at Albi...
Read MoreOur latest investorview is, this week, with Jay Goth, Managing Partner of t...
Read MoreIn a new regular feature for Drugs & Dealers, we’ll be interviewing some of...
Read More
Andrew J. Holman, Co-Founder and Chief Executive O...
Read MoreFiona Nielsen, Founder and Chief Executive Officer...
Read MoreStéphane Boissel, Chief Executive Officer at TxCel...
Read MoreDieter Willbold, Founder and Chairman of the Super...
Read MoreElaine Warburton OBE, Chief Executive Officer at Q...
Read MoreErik Kinnman, Chief Executive Officer at Sweden’s ...
Read MorePeter Garcia, Vice President and Chief Financial O...
Read MoreLionel Segard, Chairman and Chief Executive Office...
Read More
In looking at deals each month, certain patterns start to emerge. This mon...
Read MoreFor some time now, Medius has noted that corporate acquisitions are in decl...
Read MoreOctober 2017 has proved to be a very interesting month, with our Deal Watch...
Read MoreThe trend we have noted previously in the decline in the number of pharma M...
Read MoreThere is plenty of evidence that the number and value of biopharma M&A and ...
Read MoreThe cheque books have been out in force in July, and payments were for subs...
Read MoreLondon, 9th June 2017 - Biotech and Money is delighted to announce an excit...
Read More
Biotech and Money is the influential community of senior life science decision makers
© 2018 All Rights Reserved By Biotech and Money
